Viswa Colluru, Enveda Biosciences CEO
'As the market has turned': Enveda secures $68M to move revised pipeline into the clinic in 2023
Enveda Biosciences will enter the clinic next year with at least one of its three main programs thanks to a $68 million boost in financing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
